VALLEFUOCO, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 82
AS - Asia 37
EU - Europa 32
AF - Africa 7
Totale 158
Nazione #
US - Stati Uniti d'America 80
SG - Singapore 20
IT - Italia 15
CN - Cina 12
CI - Costa d'Avorio 7
FI - Finlandia 5
IN - India 5
GB - Regno Unito 4
IE - Irlanda 4
NL - Olanda 4
CA - Canada 2
Totale 158
Città #
Singapore 17
Chandler 12
Millbury 6
Princeton 6
Amsterdam 4
Beijing 4
Des Moines 4
Santa Clara 4
Ashburn 3
Boston 3
Nanjing 3
Balzola 2
Naples 2
Salerno 2
Shenyang 2
Jiaxing 1
Ottawa 1
Pune 1
San Francisco 1
San Mateo 1
Taizhou 1
Tianjin 1
Toronto 1
Wilmington 1
Totale 83
Nome #
Anti-JC virus antibodies index and JCV DNA concordance and markers of active viral replication: true exposure to JCV virus in natalizumab treated patients. In MULTIPLE SCLEROSIS JOURNAL (Vol. 19, No. 11, pp. 495-496). 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND: SAGE PUBLICATIONS LTD. 35
JCV antibodies seroconversion on natalizumab treatment and predictive factors: preliminary data. 30
Evaluation of the Automated QIAsymphony SP/AS Workflow for Cytomegalovirus DNA Extraction and Amplification from Dried Blood Spots 24
Fourth generation assays for HIV testing 23
Expression of GM-CSF receptor and "in vitro" effects of GM-CSF on human fibroblasts 17
Clinico-pathological significance of hepatitis C virus core antigen levels in chronic infection 16
Anti-HDV reflex testing in HBsAg-positive subjects: An efficacious strategy to identify HDV infection 12
Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents 11
Totale 168
Categoria #
all - tutte 923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 923


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 2 0 0 1 4 0
2020/20215 0 0 0 0 0 2 0 0 0 0 3 0
2021/202225 0 0 0 0 0 1 0 2 4 1 4 13
2022/202331 6 2 1 1 4 5 0 1 4 4 3 0
2023/202426 0 7 0 2 1 3 0 7 0 0 3 3
2024/202534 16 15 0 1 2 0 0 0 0 0 0 0
Totale 168